共 50 条
- [21] Etrolizumab in moderate-to-severe ulcerative colitis [J]. LANCET, 2014, 384 (9940): : 285 - 286
- [22] Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I567 - I568
- [26] Certolizumab Pegol Induces Clinical Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: An Open-Label Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S425 - S425
- [29] Clinical Remission Using the Patient-Reported Ulcerative Colitis Electronic Diary (UC e-Diary) in Adults With Moderate-to-Severe Ulcerative Colitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
- [30] Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S441 - S442